Headlands Technologies »

Agios Pharmaceuticals shares owned by Headlands Technologies

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $198k 8.9k 22.27
2023-09-30 $224k 9.0k 24.75
2023-06-30 $195k 6.9k 28.32

More positions owned by Headlands Technologies

Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Pepsi (PEP)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Workday Cl A (WDAY)
Citigroup Com New (C)
Icici Bank Adr (IBN)
Synopsys (SNPS)
Meta Platforms Cl A (META)

View all positions for Headlands Technologies

Top funds holding Agios Pharmaceuticals

Vanguard Group
Bellevue Group
Dimensional Fund Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Arrowpoint Asset Management
Citadel Advisors
Bnp Paribas Investment Partners
Fisher Investments
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Frazier Life Sciences Management
Hudson Bay Capital Management
Charles Schwab Investment Management
Assenagon Asset Management

View all funds holding Agios Pharmaceuticals